SCHEMBL26645413

SCHEMBL26645413

COc1ccc(-c2nn3c(c2I)CN(C(=O)OC(C)(C)C)CC3)cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SUV39H2 Q9H5I1 6/20 0.44
▸ CFTR P13569 2/20 0.42
▸ PGK1 P00558 1/20 0.41
▸ SMPD3 Q9NY59 2/20 0.40
▸ CACNB4 O00305 2/20 0.40
▸ CACNA1A O00555 2/20 0.40
▸ CACNA1G O43497 2/20 0.40
▸ CACNG3 O60359 2/20 0.40
▸ CACNA1F O60840 2/20 0.40
▸ CACNA1H O95180 2/20 0.40
▸ CACNB3 P54284 2/20 0.40
▸ CACNA2D1 P54289 2/20 0.40
▸ CACNG7 P62955 2/20 0.40
▸ CACNA1B Q00975 2/20 0.40
▸ CACNA1D Q01668 2/20 0.40
▸ CACNB1 Q02641 2/20 0.40
▸ CACNG1 Q06432 2/20 0.40
▸ CACNB2 Q08289 2/20 0.40
▸ CACNA1S Q13698 2/20 0.40
▸ CACNA1C Q13936 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30622957 1.00 SUV39H2 (0.44) SUV39H2CFTRPGK1SMPD3CACNB4
SCHEMBL26645586 0.89 CSNK1E (0.44) CFTRSMPD3CSNK1EALKPIK3CD
SCHEMBL30623018 0.89 CSNK1E (0.44) CFTRSMPD3CSNK1EALKPIK3CD
SCHEMBL26645364 0.86 CSNK1E (0.45) CSNK1ECNR1CNR2
SCHEMBL30622740 0.85 CFTR (0.42) SUV39H2CFTRPGK1SMPD3CACNB4
SCHEMBL26645587 0.85 CFTR (0.42) SUV39H2CFTRPGK1SMPD3CACNB4
SCHEMBL26645223 0.84 ALDH1A1 (0.48) MEN1ALDH1A1KMT2ACSNK1EMAPT
SCHEMBL16711450 0.81 CSNK1E (0.52) MEN1KMT2ACSNK1E
SCHEMBL26645023 0.81 MERTK (0.43) SUV39H2CACNB4CACNA1ACACNA1GCACNG3
SCHEMBL30622947 0.80 CFTR (0.44) SUV39H2CFTRPGK1SMPD3CACNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 — — WO disclosed
Send feedback